MFN-driven drug price reductions in the US are unlikely to have a big impact pharma R&D spending, experts agree.

Advanced biotech equipment, driven by R&D investment and personalized medicine, is essential for scalable drug production and ...

From October 17 to 21, the European Society for Medical Oncology (ESMO) Annual Congress convened in Berlin, bringing together global leaders in oncology ...

Singapore-based pharmaceutical companies are seeking clarity on tariff exemptions amid new US tariffs, impacting billions in ...

The number of “innovation champions” in the pharma industry working on infectious diseases is dropping — and that’s troubling ...

HYDERABAD: Noting that India ranks third globally in pharmaceutical supply by volume but only 14th by value, Dr N Madhusudhan ...

Data management, study design, and the groundwork needed to build pharma’s digital revolution. As the pharmaceutical industry ...

AstraZeneca has now joined Pfizer in agreeing to sell its drugs to state Medicaid programs at “most-favored-nation” pricing ...

Biopharma data showed M&A strength, selective venture capital favoring Phase II, record obesity deals, and significant ...

From October 17 to 21, the European Society for Medical Oncology (ESMO) Annual Congress convened in Berlin, bringing together global leaders in oncology and pharmaceutical innovation. Representing ...

XPH offers diversified exposure to large-, mid-, and small-cap pharma stocks, balancing blue-chip stalwarts and speculative ...

BW Pharma Awards 2025 recognizes India’s pharmaceutical innovators driving excellence, ethics, and transformation in global ...